A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
Applying to 2101, Washington University Therapeutics (WT) CRS · St Louis, Missouri
Answer a few short questions to share with the research team.